OBJECTIVE: The aim of this study was to determine whether educational length affects @entity1486 (PSA) testing and the time to prostate biopsy for @entity1 with raised PSA values. MATERIALS AND METHODS: Using register data on all @entity1 in Stockholm County in 2013 (n   =   1,052,841), the limited-duration point prevalence of PSA testing and time between test and prostate biopsy or repeat testing were analysed. Patterns of follow-up were assessed using Kaplan-Meier product limit estimators and Cox proportional hazard models. Educational length was categorized as short ( <=9 years), intermediate (10-12 years) or long (>= 13 years). RESULTS: PSA testing increased with educational length in all age groups. Among @entity1 aged 50-69 years, 61% with long and 54% with short education had had a PSA test within the preceding 10 years (p   <   0.001). In @entity1 with PSA 4-10   ng/ml, 40% [95% confidence interval (CI) 38-41] with long and 27% (95% CI 26-29) with short education underwent a prostate biopsy within 12 months. After adjusting for PSA level and age, educational length was still associated with the chance of having a prostate biopsy in @entity1 with PSA 4-10   ng/ml (hazard ratio 1.22, 95% CI 1.12-1.31), but not in @entity1 with higher PSA values. CONCLUSION: PSA testing increased with educational length. @entity1 with long education were more likely to have a prostate biopsy after an increased PSA value below 10   ng/ml than @entity1 with short education. These differences may contribute to the @entity263 outcomes observed among @entity1 with lower socioeconomic status.

A population-based study on the association between educational length, XXXX testing and use of prostate biopsies.

@entity1 :: ('9606', 'Species') :: ['Men', 'men'] @entity263 :: ('MESH:D011471', 'Disease') :: ['worse prostate cancer'] @entity1486 :: ('354', 'Gene') :: ['prostate-specific antigen']
@entity1486 :: (354,Gene) :: ['prostate-specific antigen']
